NCT00456833View on ClinicalTrials.gov

Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy

PHASE1CompletedINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

March 31, 2011

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

RAD001

DRUG

erlotinib

Trial Locations (14)

30322

Novartis Investigative Site, Atlanta

37203

Novartis Investigative Site, Nashville

44805

Novartis Investigative Site, Saint-Herblain Cédex

53792

Novartis Investigative Site, Madison

55905

Novartis Investigative Site, Rochester

94805

Novartis Investigative Site, Villejuif

115478

Novartis Investigative Site, Moscow

60637-1470

Novartis Investigative Site, Chicago

02115

Novartis Investigative Site, Boston

77030-4009

Novartis Investigative Site, Houston

V7C 5L9

Novartis Investigative Site, Richmond

M5G 2M9

Novartis Investigative Site, Toronto

H2L 4M1

Novartis Investigative Site, Montreal

DK-2730

Novartis Investigative Site, Herlev

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY